Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2009 1
2010 1
2011 1
2012 2
2015 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: dihydroxypropanamide
Page 1
Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF.
Sova M, Kovac A, Turk S, Hrast M, Blanot D, Gobec S. Sova M, et al. Bioorg Chem. 2009 Dec;37(6):217-22. doi: 10.1016/j.bioorg.2009.09.001. Epub 2009 Sep 10. Bioorg Chem. 2009. PMID: 19804894
The IC(50) values of these inhibitors were in the micromolar range, which makes them a promising starting point for the development of multiple inhibitors of Mur ligases as potential antibacterial agents. In addition, 1-(4-methoxyphenylsulfonamido)-3-morpholinopropan-2-yl …
The IC(50) values of these inhibitors were in the micromolar range, which makes them a promising starting point for the development of multi …
A novel sulfonamide agent, MPSP-001, exhibits potent activity against human cancer cells in vitro through disruption of microtubule.
Liu ZL, Tian W, Wang Y, Kuang S, Luo XM, Yu Q. Liu ZL, et al. Acta Pharmacol Sin. 2012 Feb;33(2):261-70. doi: 10.1038/aps.2011.156. Acta Pharmacol Sin. 2012. PMID: 22301862 Free PMC article.
AIM: To evaluate the anti-cancer effects of a new sulfonamide derivative, 2-(N-(3-chlorophenyl)-4-methoxyphenylsulfonamido)-N-hydroxypropanamide (MPSP-001). METHODS: Human cancer cell lines (HepG2, THP-1, K562, HGC-27, SKOV3, PANC-1, SW480, Kba, HeLa, A549, MDA-MB-453, and …
AIM: To evaluate the anti-cancer effects of a new sulfonamide derivative, 2-(N-(3-chlorophenyl)-4-methoxyphenylsulfonamido)-N-hydroxy …